TABLE 6.
OR (95% CI) | P | Multivariate model 1 (OR) | Multivariate model 1 (P) | Multivariate model 2 (OFs) (OR) | Multivariate model 2 (P) | |
---|---|---|---|---|---|---|
Age (years) | 1.013 (1.002–1.025) | 0.019 | 1.022 (1.008–1.036) | 0.003 | 1.014 (1.000–1.029) | 0.052 |
Sex (Female) | 0.727 (0.521–1.015) | 0.061 | 0.850 (0.575–1.256) | 0.414 | 0.799 (0.539–1.185) | 0.265 |
TLC (×109) | 1.043 (1.022–1.064) | <0.001 | 1.012 (0.989–1.037) | 0.307 | 1.006 (0.983–1.030) | 0.623 |
INR | 1.742 (1.493–2.033 | <0.001 | 1.579 (1.320–1.889) | <0.001 | ||
Creatinine (mg/dl) | 1.391 (1.241–1.559) | <0.001 | 1.160 (1.032–1.304) | 0.013 | ||
Total bilirubin (mg/dl) | 1.013 (1.000–1.027) | 0.058 | 1.013 (0.995–1.031) | 0.151 | ||
Albumin (g/dl) | 0.745 (0.600–0.926) | 0.008 | 0.862 (0.667–1.114) | 0.257 | 0.878 (0.679–1.135) | 0.320 |
Mean arterial pressure (mm Hg) | 0.988 (0.978–0.998) | 0.022 | 0.995 (0.986–1.003) | 0.240 | ||
Overt‐HE | 3.724 (2.744–5.053) | <0.001 | ||||
Organ failures | ||||||
HE | 4.462 (3.064–6.497) | <0.001 | ||||
Liver | 1.378 (1.021–1.859) | 0.036 | 1.814 (1.215–2.708) | 0.004 | ||
Kidney | 3.982 (2.873–5.519) | <0.001 | 2.442 (1.669–3.572) | <0.001 | ||
Coagulation | 3.355 (2.456–4.583) | <0.001 | 2.781 (1.930–4.007) | <0.001 | ||
Circulatory | 2.213 (1.567–3.125) | <0.001 | 1.534 (1.007–2.337) | 0.046 | ||
Respiratory | 2.605 (1.930–3.518) | <0.001 | 2.057 (1.403–3.017) | <0.001 | ||
Baseline HE and infection groups | ||||||
No baseline HE no infection | 1 | 1 | 1 | |||
Overt HE no baseline infection | 4.466 (3.113–6.408) | <0.001 | 3.711 (2.488–5.536) | <0.001 | 3.312 (2.193–5.002) | <0.001 |
No baseline HE baseline infection | 3.612 (2.277–5.730) | <0.001 | 3.181 (1.918–5.275) | <0.001 | 3.018 (1.802–5.053) | <0.001 |
Overt HE baseline infection | 7.634 (4.498–12.956) | <0.001 | 5.388 (3.021–9.611) | <0.001 | 4.586 (2.540–8.277) | <0.001 |
Abbreviations: HE, hepatic encephalopathy; INR, international normalised ratio; TLC, total leucocyte count.